SMRT Sequencing Chosen for Ambitious Effort to Generate Reference Genomes for 26 Maize Lines MENLO PARK, Calif., July 10, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the…
New Tools Unveiled at ASM Annual Meeting Enable Microbiologists to Do More, See More Than Ever Before MENLO PARK, Calif., June 07, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California…
Gonorrhoea, Deadly Plague and Dysentery Among Collection of Bacterial Genomes Now Publicly Available Through Collaboration with Pacific Biosciences HINXTON, United Kingdom and MENLO PARK, Calif., June 06, 2018 (GLOBE NEWSWIRE)…
MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year…
MENLO PARK, Calif., May 02, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced financial results for its first quarter ended March 31, 2018. Total revenue for…
MENLO PARK, Calif., April 20, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its First Quarter 2018 Financial Results on…
NIH-funded Program Focuses on Challenging Pediatric Cases; SMRT Sequencing Expected to Increase Solve Rate for Genetic Diagnosis MENLO PARK, Calif., April 11, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California,…
MENLO PARK, Calif., March 27, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced a purchase order for 10 PacBio® Sequel®…
MENLO PARK, Calif., March 22, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that Judge Leonard P. Stark of the…
Clinical Research Effort Establishes New Quality Control Standards and Reveals Previously Undetected Risks for Gene Therapy Delivery MENLO PARK, Calif., March 15, 2018 (GLOBE NEWSWIRE) — A new publication in…
MENLO PARK, Calif., March 13, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the U.S. Patent and Trademark Office…
New Polymerase and Software Releases Improve Structural Variant Detection, Targeted Sequencing and RNA Sequencing Applications MENLO PARK, Calif., March 07, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB),…
MENLO PARK, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) (the “Company”) today announced that it has priced its previously announced underwritten public offering of…
MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that it intends to offer and sell shares of its common stock in…
MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California Inc., (Nasdaq:PACB) today announced its Single Molecule, Real-Time (SMRT®) Sequencing technology will be demonstrated in several presentations and…
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.